Michael Burgess
Impact in
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
-
- Pharmacological Effects and Toxicity Studies
Papers in
- Oncology 4
- Drug Transport and Resistance Mechanisms 3
-
- Epilepsy research and treatment 3
- Cerebral Palsy and Movement Disorders 1
- Co-authors
- Dinesh P. de Alwis (5 shared papers)Anne H. Dantzig (1 shared paper)Sophie Callies (5 shared papers)Alan Sandler (2 shared papers)Leon Aarons (3 shared papers)Christopher A. Slapak (2 shared papers)Pier Luigi Zinzani (1 shared paper)Charles Dumontet (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)British Journal of Clinical Pharmacology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)American Journal of Occupational Therapy (1 paper)Advanced Drug Delivery Reviews (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Michael Burgess
15 papers receiving 484 citations
Peers
Comparison fields: 5 of 71
- Oncology 290
- Pediatrics, Perinatology and Child Health 88
- Pharmacology 43
- Infectious Diseases 62
- Toxicology 10
Countries citing papers authored by Michael Burgess
This map shows the geographic impact of Michael Burgess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Burgess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Burgess more than expected).
Fields of papers citing papers by Michael Burgess
This network shows the impact of papers produced by Michael Burgess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Burgess. The network helps show where Michael Burgess may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Burgess, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 120 | |
| 2 | 2003 | 100 | |
| 3 | 2010 | 76 | |
| 4 | 2007 | 66 | |
| 5 | 2003 | 38 | |
| 6 | 2003 | 26 | |
| 7 | 2004 | 26 | |
| 8 | 2010 | 20 | |
| 9 | 1989 | 7 | |
| 10 | 2024 | 4 | |
| 11 | 2023 | 4 | |
| 12 | 2021 | 3 | |
| 13 | 2023 | 2 | |
| 14 | 2007 | 2 | |
| 15 | 2004 | 1 |
About Michael Burgess
Michael Burgess is a scholar working on Oncology, Psychiatry and Mental health, Molecular Biology, Infectious Diseases and Organic Chemistry, having authored 15 papers that have together received 495 indexed citations. Recurring topics across this work include Epilepsy research and treatment (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Pharmacogenetics and Drug Metabolism (1 paper), HIV/AIDS drug development and treatment (1 paper), Glycosylation and Glycoproteins Research (1 paper), Pharmacological Effects and Toxicity Studies (1 paper), Cerebral Palsy and Movement Disorders (1 paper) and Biochemical and Molecular Research (1 paper). The work is most often cited by research in Oncology (290 citations), Pediatrics, Perinatology and Child Health (88 citations), Pharmacology (43 citations), Infectious Diseases (62 citations) and Toxicology (10 citations). Michael Burgess has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Dinesh P. de Alwis, Anne H. Dantzig, Sophie Callies, Alan Sandler, Leon Aarons, Christopher A. Slapak, Pier Luigi Zinzani, Charles Dumontet, Franck Morschhauser and Karen Fife. Their work appears in journals such as Clinical Cancer Research, British Journal of Clinical Pharmacology, Cancer Chemotherapy and Pharmacology, American Journal of Occupational Therapy and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.